Due to its insulin-sensitizing functions during the hyperglycemic state and protective role in vasculature and adipose states, vaspin has been speculated as a beneficial adipokine and therapeutic candidate in metabolic disorders, thus providing the reasoning for undertaking this study [4]. This evidence concerns the gene SERPINA12 and metabolic disease.